Parameter
| Biomarker | Lachnospira | Full name | Lachnospira spp. | Molecular Type | Microbes |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Diagnosis, Prognosis | ||
| Disease | Esophageal Carcinoma | Disease Subtypes | / | ||
| Organ | Esophagus | Test Sample / Technology Platform | Stool (16S rRNA sequencing) | ||
| Pathobiological Mechanisms | They belong to intestinal beneficial bacteria, and their decreased abundance is related to the occurrence of ESCC. They affect tumor progression by regulating intestinal barrier function and inflammatory response | ||||
| Clinical Availability Status | Clinical research phase: multiple fecal microbiota studies have confirmed its diagnostic value | ||||
| Notes and Dynamics | It is a key marker of intestinal microbiota imbalance in ESCC and provides a target for intestinal microecological intervention | ||||